All News

Older adults with diabetes are experiencing declines in all-cause mortality rates, whereas younger adults continue to be affected more by the condition.

Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.

Quality, speed, and price has been referred to as the "Unattainable Triangle".

FDA approval decision expected in the second quarter of 2020.

Proton pump inhibitors (PPIs) may be linked to concentration and memory problems in individuals with a history of breast cancer.

As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade. 

Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.

The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.

Let’s take a look at some of the most common issues pharmacists are facing, as seen recently on Facebook.

Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications. 

The impact of herpes zoster can be measured in a number of different ways.

The NACDS and NCPA praised the United States Supreme Court's decision to hear a case involving states’ regulation of pharmacy benefit managers.

The FDA Committees voted against recommending approval of Nektar Therapeutics' oxycodegol.

Novavax’s recombinant quadrivalent flu vaccine candidate (NanoFlu) is being evaluated in an ongoing phase 3 clinical study for use in older adults.

Here are 4 pharmacy-related New Year’s resolutions that can help enhance your pharmacy services.

Shingles vaccination recommended by CDC and ADCES.

The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.

Progress has been made, but there’s still a long road ahead.

Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.

Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study. 

Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.

Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.

A study evaluated the ability of untrained individuals to use different forms of naloxone administration.

Here are the top drugs expected to be approved this year.

NACDS says DIR fees, other policies need to change.

Viaskin Peanut (DBV Technologies) achieved durable, long-term clinical benefit in peanut-allergic children.

Individuals with a history of heart disease may be at an increased risk of developing kidney failure.

In a new lawsuit, CVS, Walgreen, Rite Aid, and other major pharmacy chains said that they are not to blame in federal opioid litigation

Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.